Precision Oncology in Melanoma Patients Treated with Immunotherapy - Biognosys

Precision Oncology in Melanoma Patients Treated with Immunotherapy

This webinar discusses how unbiased discovery proteomics can be used to identify new key mechanisms and signatures supporting clinical decision-making for melanoma patients. Paolo A. Ascierto, MD of Italy’s National Tumor Institute and Kamil Sklodowski of Biognosys elaborate on the promise of proteomics for addressing the unmet medical needs of melanoma patients undergoing immunotherapy.

GenomeWebinar June 16, 2021
Precision Oncology in Melanoma Patients Treated with Immunotherapy: Clinical and Technological Perspective

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    Spectronaut® 16

    The Deepest Proteome
    Coverage Available

    New: Spectronaut® 16

    The Deepest Proteome Coverage Available

    learn more